AI is changing the way pharma delivers omnichannel, but is it improving engagement or just adding to the noise? In this episode, we explore how pharma can avoid repeating past mistakes, how hyper-personalization and localization are being applied across markets, and why human insight is the key to making AI truly effective in reaching doctors.
All content for DELTAMV’S INSIGHT BITES is the property of DeltaMV Knowledge Solutions and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
AI is changing the way pharma delivers omnichannel, but is it improving engagement or just adding to the noise? In this episode, we explore how pharma can avoid repeating past mistakes, how hyper-personalization and localization are being applied across markets, and why human insight is the key to making AI truly effective in reaching doctors.
The pharmaceutical industry is using models for treatment adoption that can be traced back over a hundred years. At DeltaMV, we question how relevant these models are in today’s digital world. Should we be looking over the fence at FMCG models and move on from the established approach? In this episode, we share key insights from our conversations with clinicians across Asia-Pacific around how they adopt new treatments.
DELTAMV’S INSIGHT BITES
AI is changing the way pharma delivers omnichannel, but is it improving engagement or just adding to the noise? In this episode, we explore how pharma can avoid repeating past mistakes, how hyper-personalization and localization are being applied across markets, and why human insight is the key to making AI truly effective in reaching doctors.
